Application of Heparin-free ECMO in Severe Patients

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000031266

Enrollment

Unknown

Registered

2020-03-26

Start date

2020-03-30

Completion date

Unknown

Last updated

2020-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Patients treating by Heparin-free ECMO

Interventions

Heparin-free group:NA

heparin group:NA

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years; 2. With cardiopulmonary failure due to reversible causes; 3. With indications recommended by ELSO; 4. Patients with informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with irreversible brain damage after cardiac arrest; 2. On the verge of death; 3. Patients with terminal stage of malignant tumor; 4. With irreversible serious central nervous system diseases such as cerebral hernia formation and flat brain waves; 5. Patients with abnormal blood vessels unable to complete ECMO catheterization.

Design outcomes

Primary

Measure	Time frame
Survival to discharge;Bleeding complications;Thrombotic complications;Transfusion requireent;	—

Secondary

Measure	Time frame
Number of oxygenator changes;	—

Countries

China

Contacts

Public ContactXiaosong Qiu

The Affiliated Hospital of Xuzhou Medical University

34104070@qq.com+86 17705225559

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026